US · NOVTU · HARDWARE, EQUIPMENT & PARTS
Novanta Inc. Tangible Equity Units (NOVTU) intrinsic value and stock valuation
$45.64as of 2026-11-21 · Mkt cap 2.29B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Novanta Inc. Tangible Equity Units DCF and intrinsic value
InvestorsCraft values NOVTU with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from NOVTU’s statements →
Novanta Inc. Tangible Equity Units Graham Number
Graham Number: $34.48d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2025–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Financials
Statements by fiscal year
| 2025 | |
|---|---|
| Revenue | $980.6M |
| Operating income | $116.7M |
| Net income | $53.8M |
| EPSd | $1.47M |
| Operating cash flow | $64.1M |
| Capital expenditure | -$-15.63M |
| Free cash flow | $48.4M |
| Total assets | $1.81B |
| Total debt | $341.6M |
| Net debt | -$-39.26M |
| Total equity | $1.31B |
| Cash and short-term investments | $380.9M |
Income statement
| 2025 | |
|---|---|
| Revenue | $980.6M |
| Cost of revenue | $572.8M |
| Gross profit | $407.8M |
| Research and development expenses | $95.5M |
| Selling, general and administrative expenses | $195.7M |
| Other expenses | $0.00 |
| Operating expenses | $291.1M |
| Cost and expenses | $863.9M |
| Interest income | $0.00 |
| Interest expense | $21.5M |
| Depreciation and amortization | $61.9M |
| Ebitda | $153.1M |
| Operating income | $116.7M |
| Total other income/expenses, net | -$-47.02M |
| Income before tax | $69.6M |
| Income tax expense | $15.8M |
| Net income | $53.8M |
| Weighted average shares outstanding | $36.6M |
| Weighted average diluted shares outstanding | $36.7M |
Balance sheet
| 2025 | |
|---|---|
| Cash and short-term investments | $380.9M |
| Net receivables | $184.9M |
| Inventory | $188.3M |
| Total current assets | $782.6M |
| Property, plant and equipment, net | $160.2M |
| Goodwill and intangible assets | $828.1M |
| Long-term investments | $0.00 |
| Total non-current assets | $1.02B |
| Total assets | $1.81B |
| Accounts payable | $94.9M |
| Short-term debt | $49M |
| Deferred revenue | $11M |
| Total current liabilities | $212.4M |
| Long-term debt | $292.6M |
| Deferred revenue, non-current | $0.00 |
| Total non-current liabilities | $280.5M |
| Capital lease obligations | $41.2M |
| Total liabilities | $492.8M |
| Common stock | $423.9M |
| Retained earnings | $321.4M |
| Accumulated other comprehensive income (loss) | -$-3M |
| Total equity | $1.31B |
| Total investments | $0.00 |
| Total debt | $341.6M |
| Net debt | -$-39.26M |
Cash flow statement
| 2025 | |
|---|---|
| Net income | $53.8M |
| Depreciation and amortization | $61.9M |
| Stock-based compensation | $0.00 |
| Change in working capital | -$-75.13M |
| Accounts receivable | -$-27.27M |
| Inventory | -$-36.1M |
| Accounts payable | $3.71M |
| Net cash provided by operating activities | $64.1M |
| Investments in property, plant and equipment | -$-15.63M |
| Acquisitions, net | -$-58.69M |
| Net cash used for investing activities | -$-74.32M |
| Common stock issued | $614.4M |
| Common stock repurchased | -$-39.28M |
| Dividends paid | $0.00 |
| Net cash used for financing activities | $276.3M |
| Net change in cash | $266.9M |
| Cash at end of period | $380.9M |
| Operating cash flow | $64.1M |
| Capital expenditure | -$-15.63M |
| Free cash flow | $48.4M |
Line items
Line items
Line items
About Novanta Inc. Tangible Equity Units
Novanta Inc. specializes in the development, manufacturing, and global commercialization of advanced components and integrated sub-systems across photonics, vision, and precision motion technologies. Catering to original equipment manufacturers (OEMs), its solutions are vital for medical and industrial applications worldwide. The company's Photonics segment delivers sophisticated solutions, encompassing laser scanning, beam delivery systems, various laser types (CO2, solid state, ultrafast), and optical light engines. These innovations find applications in industrial processing, precise measurement (metrology), medical and life science imaging, genetic sequencing, and diverse medical laser interventions. The Vision division supplies an array of medical-grade technologies, such as insufflators, pumps, and related disposables, alongside advanced visualization solutions. It also offers wireless communication, video recording devices, and video integration systems specifically designed for operating room environments, in addition to optical data acquisition, machine vision, radio frequency identification (RFID), thermal chart recorders, spectrometry, and embedded touchscreen technologies. Furthermore, its Precision Motion segment provides expertise in optical and inductive encoders, high-precision motors, advanced servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-effectors, and air bearing systems, including spindles. Novanta Inc. employs a diverse sales strategy, leveraging its direct sales force alongside resellers, distributors, and system integrators. Its extensive product portfolio is marketed under a collection of well-known brands, including Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Tracing its origins to 1968, Novanta Inc. was formerly known as GSI Group, Inc., adopting its current name in May 2016. The company's headquarters are situated in Bedford, Massachusetts.
- CEO
- Matthijs Glastra
- Employees
- 3K
- Beta
- 1.68
Explore
Frequently asked questions
What is the intrinsic value of Novanta Inc. Tangible Equity Units (NOVTU)?
InvestorsCraft does not currently publish an intrinsic value for NOVTU. How the IC value is calculated.
Is NOVTU undervalued?
InvestorsCraft does not publish an undervaluation signal for NOVTU at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.